NEW YORK (GenomeWeb) – Microbiome health management firm DayTwo announced on Tuesday that it has raised $12 million in a Series A financing round. Participants in the round include Johnson & Johnson Innovation-JJDC, Seventure Partners, the Mayo Clinic, DayTwo Cofounder Marius Nacht, and other private investors. DayTwo has raised $17 million to date.
Israeli healthtech DayTwo has raised $12m in a Series A financing round, featuring Johnson & Johnson Innovation-JJDC, the Mayo Clinic, Marius Nachtfounder DayTwo Co- and Seventure Partners, to name some. DayTwo's app offers users personalised nutrition services, based on the DNA sequencing of a customer's gut bacteria. The funds will be used to expand the product, as well as add to engineering, and data science teams in Tel Aviv and San Francisco.